Safety of empagliflozin in patients with Type 2 Diabetes and chronic kidney disease: pooled analysis of placebo-controlled clinical trials. 1 Jul, 2022 | 10:44h | UTC Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials – Diabetes Care